Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Recurrence 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Neoplasms 1Multiple Myeloma 1Inflammation 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Cytopenia 1Burkitt Lymphoma 1

Interventions

Surgical Procedures, Operative 2Blood Specimen Collection 2ziprasidone 1semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Zolpidem 1Weights and Measures 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Topiramate 1Tobramycin 1Tirzepatide 1Spironolactone 1Sevelamer 1Rocuronium 1Radiotherapy 1Qsymia 1Piperacillin, Tazobactam Drug Combination 1Pioglitazone 1Phentermine 1Pentobarbital 1Oxycodone 1Nifedipine 1Neoadjuvant Therapy 1Naltrexone 1Nafcillin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Inflammation × Immunotherapy, Adoptive × Clear all
NCT06439173 2024-06-03

Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment

Instituto de Investigación Biomédica de Salamanca

Recruiting
40 enrolled
Classical hematologyLymphoid

Cytopenia, Inflammation, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡